Skip to main content
Clinical Trials/NCT00817791
NCT00817791
Completed
Not Applicable

Phase 1 Study of Protective Effect of Hyperbaric Oxygen Preconditioning on Brain and Myocardium Injury During CABG Surgery

Xijing Hospital0 sites49 target enrollmentNovember 2007

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Brain Injury
Sponsor
Xijing Hospital
Enrollment
49
Primary Endpoint
Post operative cognitive dysfunction
Status
Completed
Last Updated
16 years ago

Overview

Brief Summary

Animal studies have shown that preconditioning with hyperbaric oxygen can induce central nervous system and heart ischemic tolerance. This study was designed to determine the protective effect of hyperbaric oxygen preconditioning on brain and myocardium ischemia-reperfusion injury during coronary artery bypass graft surgery.

Detailed Description

60 patients scheduled to undergo coronary revascularization were recruited for this trial. Exclusion criteria included Emergency operation, age older than 80 years, learning difficulty, previous cerebrovascular disease, visual or hearing impairment, history of pneumothorax, Claustrophobia, middle ear disease, EF \< 35%. Patients were randomized either to the control group or hyperbaric oxygen group. The laboratory analysis of markers included S100B, NSE and troponin I. The assessment of cognitive dysfunction was performed 5 days before surgery and 7 days after surgery and haemodynamic measurements, length of stay in ICU, length of stay in hospital post-operation were recorded.

Registry
clinicaltrials.gov
Start Date
November 2007
End Date
March 2009
Last Updated
16 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Male

Investigators

Sponsor
Xijing Hospital

Eligibility Criteria

Inclusion Criteria

  • Patients scheduled to undergo coronary revascularization surgery.

Exclusion Criteria

  • Emergency operation
  • Age older than 80 years
  • Learning difficulty
  • Previous cerebrovascular disease
  • Visual or hearing impairment
  • History of pneumothorax, claustrophobia, middle ear disease, EF \< 35%

Outcomes

Primary Outcomes

Post operative cognitive dysfunction

Time Frame: 5 days before surgery and 7 days after surgery

Secondary Outcomes

  • S100B protein,NSE and Troponin I(Within the first 3 days after surgery)

Similar Trials